(Total Views: 653)
Posted On: 06/05/2022 9:04:13 AM
Post# of 154115

Journal Of Clinical oncology / CCR5 Safety, efficacy, and clinical outcomes of the anti-CCR5 inhibitor (Leronlimab) : A pooled analysis of three clinical trials in patients with mTNBC.
https://ascopubs.org/doi/abs/10.1200/JCO.2022...e&s=cl
Credit Bluemoon @ I Village
https://ascopubs.org/doi/abs/10.1200/JCO.2022...e&s=cl
Credit Bluemoon @ I Village

